Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-28
2007-08-28
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S012000
Reexamination Certificate
active
11266072
ABSTRACT:
The invention relates to compounds of formula (I):wherein:X represents oxygen or sulphur,R1represents linear or branched (C1-C6)alkyl substituted by one or more halogen atoms,R2represents hydrogen, halogen or hydroxy,R3represents a group R4or —Y—R5wherein R4, Y and R5are as defined in the description,and medicinal products containing the same which are useful in treating or preventing disorders associated with AMPA flux.
REFERENCES:
Alt et al. Current Pharmaceutical Design, 2005, 11, 1511-1527.
Black et al. Psychopharmacology (2005) 179: 154-163.
Maskell, et al.,Br. J. Pharmacol,2003, 140, 1313-1319.
Aracava, et al.,JPET,2005, 312, 1195-1250.
Advokat, et al.,Neurosci. Biobehav. Rev.,1992, 16, 13-24.
Danysz, et al.,Behav. Pharmacol.,1995, 6, 455-474.
Lynch,Neurobiology of Learning and Memory,1998, 70, 82-100.
Robbins, et al.,TRENDS in Pharmacological Sciences,2006, 27 (3), 141-148.
Bliss, et al.,Nature,1993, 361, 31-39.
Ito, et al.,Journal of Physiology,1990, 424, 533-543.
Cumin, et al.,Psychopharmacology,1982, 78, 104-111.
Arai, et al.,Brain Res.,1994, 638, 343-346.
Miu, et al.,Neuropharmacol.,2001, 40, 976-983.
Staubli, et al.,Proc. Natl. Acad. Sci.,1994, 91, 777-781.
Lebrun, et al.,European Journal of Pharmacology,2000, 401, 205-212.
Rao, et al.,Neuroscience Letters,2001, 298, 183-186.
Thompson, et al.,Proc. Natl. Acad. Sci.,1995, 92, 7667-7671.
Buccafusco, et al.,Neuropharmacol.,2004, 46, 10-22.
Porrino, et al.,PLOS Biology,2005, 3 (9), 1639-1652.
Ingvar, et al.,Exp. Neurol.,1997, 146, 553-559.
Lynch, et al.,Exp. Neurol.,1997, 145, 89-92.
Baudry,Neurobiology of Learning and Memory,2001, 76, 284-297.
Day, et al.,Nature,2003, 424, 205-209.
Lynch,Current Opinion in Pharmacology,2006, 6, 82-88.
Lin, et al.,Brain Research,2002, 955, 164-173.
Desai, et al.,Neuropharmacology,1995, 34 (2), 141-147.
Lockhart, et al.,European Journal of Pharmacology,2000, 401, 145-153.
Jhee, et al.,J. Clin. Pharmacol.,2006, 46, 424-432.
Roger, et al.,Soc. Neurosci. Abstr.,2004, Abstract No. 219.11.
Dicou, et al.,Brain Research,2003, 970, 221-225.
Bahr, et al.,Exp. Neurol.,2002, 174, 37-47.
Murray, et al.,JPET,2003, 306, 752-762.
O'Neill, et al.,European Journal of Pharmacology,2004, 486, 163-174.
O'Neill, et al.,CNS Drug Rev.,2005, 11 (1), 77-96.
Bai, et al.,Neuropharmacology,2003, 44, 1013-1021.
Lauterborn, et al.,J. of Neuroscience,2000, 20 (1), 8-21.
Carrie, et al.,Soc. Neurosci. Abstr.,2005, Abstract No. 1018.4.
Lockhart, et al.,Soc. Neurosci. Abstr.,2004, Abstract No. 92.12.
Munoz, et al.,Soc. Neurosci. Abstr.,2004, Abstract No. 85.13.
Nibuya, et al.,J. of Neuroscience,1995, 15(11), 7539-7547.
Dias, et al.,Neuropharmacology,2003, 45, 553-563.
Alt, et al.,Curr. Pharm. Des.,2005, 11 (12), 1511-1527.
Alt, et al.,Biochemical Pharmacology,2006, 71, 1273-1288.
Nakamura, et al.,Psychopharmacology,2001, 158, 205-212.
Li, et al.,Neuropharmacology,2001, 40, 1028-1033.
Knapp, et al.,European Journal of Pharmacology,2002, 440, 27-35.
Cordi Alexis
Desos Patrice
Lestage Pierre
Habte Kahsay
Hueschen and Sage
Les Laboratories Servier
LandOfFree
Benzothiadiazine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiadiazine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiadiazine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3899910